ArticleScientific reports2019

Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer.

Nikolas Tim Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.